Katie Lapidus

Associate
Full contact info

Passions

True Crime

Peloton

Experience

Cara Therapeutics, Inc. -- $40 Million Royalty Interest Purchase and Sale Agreement

November 3, 2023

Cooley advised Cara Therapeutics, Inc. on its $40 million royalty interest purchase and sale agreement with HealthCare Royalty Partners. Michael Tollini and Addison Pierce led the Cooley team advising Cara, which included Bin Wang, Xueqing Li and Jordan Verrilli. Cara, which trades on The NASDAQ Global Market as “CARA,” is a clinical-stage biotech company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors.

Related contacts

Michael Tollini
Partner, Washington DC
Addison Pierce
Associate, Chicago
Bin Wang
Special Counsel, Palo Alto
Xueqing Li
Associate, San Francisco
Jordan Verrilli
Associate, New York
Mor Agam
Associate, New York
Katherine Denby
Associate, Washington DC
Darren DeStefano
Partner, Reston
Katie Lapidus
Associate, Washington DC
Steve Flores
Partner, Chicago
Xander Lee
Partner, Los Angeles Santa Monica
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Immunology Company argenx Announces $1.27 Billion Global Offering

July 26, 2023

Cooley advised J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities and TD Cowen, representatives of the several underwriters, in the $1.27 billion follow-on offering by argenx SE, a global immunology company.

Read more

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Associate, Washington DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC
Carley Cruea
Associate, Washington DC
Bill Christiansen
Partner, Seattle
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Dr. Tian Yong Zheng
Patent Agent, Seattle

Related Practices & Industries

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

June 6, 2023

Cooley advised the underwriters in NewAmsterdam Pharma’s $181.6 million follow-on offering. NewAmsterdam is a clinical-stage biopharmaceutical company with a mission to improve care of patients with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. Lawyers Eric Blanchard, Div Gupta, Jean Park, Minkyu Park, Charles York, and Katie Lapidus led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Div Gupta
Partner, New York
Jean Park
Partner, New York
Minkyu Park
Associate, New York
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC

Related Practices & Industries

Prelude Therapeutics – $100 Million Follow-on Offering

May 18, 2023

Cooley advised the underwriters in Prelude Therapeutics’ $100 million follow-on offering. Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. Lawyers Richard Segal, Div Gupta, Darah Protas, Sam Paullin and Katie Lapidus led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Virat Gupta
Associate, Washington DC
Darah Protas
Associate, Washington DC
Samuel Paullin
Associate, Chicago
Katie Lapidus
Associate, Washington DC

Related Practices & Industries

Olink Holding AB – $116.6 Million Follow-on Offering

January 18, 2023

Cooley advised the underwriters in Olink Holding AB’s $116.6 million follow-on offering. Olink is a company dedicated to working with the scientific community on accelerating proteomics across multiple disease areas to enable new discoveries and improve the lives of patients. Lawyers Eric Blanchard, Charlie Kim, Minkyu Park, Ryan Walker, Katie Lapidus, Megan Taing and Charles York led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Charlie Kim
Partner, San Diego
Minkyu Park
Associate, New York
Katie Lapidus
Associate, Washington DC
Charles York
Associate, New York

Related Practices & Industries

View more